Skip to contentS
Skinvisible, Inc.
S
SKVISkinvisible, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$5.00K$5.00Kderived±0.0% vs Q4 2024 Net Income-$258.36K-$258.36KderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skinvisible, Inc. · CIK 1085277 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$5,000±0.0% Operating Incomederived-$114,169N/M Operating Cash Flowderived$1,975N/M Free Cash Flowderived$1,975N/M Margins · derivedGross margin100.0%±0.0 pt vs Q4 2024
Operating margin-2283.4%+1691.5 pt vs Q4 2024
Net margin-5167.1%
ended Dec 31, 2025 · filed Mar 31, 2026 · 90 d after period end